Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

-Michelle Davis, Bloomberg News Senior Deals Reporter, discusses Merck agreeing to buy Terns Pharmacueticals for $6.7 billion, giving the company access to a promising new leukemia treatment. The acquisition is expected to close in the second quarter, with Merck paying $53 per share in cash for Terns, a 6% premium to its closing price on Tuesday.

-Geetha Ranganathan, Bloomberg Intelligence Analyst on US Media, discusses the latest at Walt Disney and Netflix. Walt Disney Co. Chief Executive Officer Josh D’Amaro has seen two billion-dollar technology bets falter, with one of them unraveling entirely, just days into his new job. Separately, Netflix Inc.'s push into livestreaming mega events in Asia is set to accelerate, buoyed by hits from the World Baseball Classic to BTS's comeback show.

-Diana Rosero Pena, Bloomberg Intelligence Consumer Staples Analyst, discusses Chewy earnings. Chewy forecast sales for the year that beat analyst estimates, suggesting the online pet retailer expects strong demand to more than make up for headwinds including inflation and tariff uncertainty.

-Justin Pridon, VP, Consulting Services at Revenue Management Solutions, discusses restaurant trends from the BI Farm, Food & Fuel Conference. He talks about what restaurant menus reveal about where food demand is headed, why protein is winning, and how demand might change with rising gas prices.

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(3454)

Instant Reaction: Netflix Disappoints Again with Slow Growth

Netflix forecast a second consecutive quarter of slowing sales growth, feeding investor anxiety about the streaming giant’s future.The company projected revenue of $12.9 billion in the current quarter...

16 Jul 19min

Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu-Sam Fazeli, Bloomberg Intelligence, Director of Research: Healthc...

16 Jul 16min

Morgan Stanley Joins Wall Street Rivals’ Stock-Trading Boon

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu-Neil Sipes, Bloomberg Intelligence U.S Financials Analyst, discus...

15 Jul 5min

US Bank Earnings Surpass Wall Street Expectations

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu-Herman Chan, Senior Analyst, US Banks for Bloomberg Intelligence,...

14 Jul 4min

SK Hynix Shares Plunge Most on Record in Deepening Korea Selloff

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu-Mandeep Singh, Global Head of Tech Research for Bloomberg Intelli...

13 Jul 17min

Bloomberg Money: SK hynix, Federal Reserve Trust, Prenups

Bloomberg Money takes the pulse of your financial life, powered by the reporting of our global newsroom. On this episode: Bloomberg's Katie Greifeld, David Gura, and Mandeep Singh join Scarlet Fu an...

10 Jul 39min

SK Hynix ADRs Surge After Record $26.5 Billion US Offering

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu-Anthony Hughes, Bloomberg US Equity Capital Markets Reporter, dis...

10 Jul 24min

Zuckerberg Pledges ‘Aggressive’ Pricing With Meta’s First Pay-to-Use AI

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence hosted by Paul Sweeney and Jess Menton-Kurt Wagner, Bloomberg Senior Reporter covering social media, di...

9 Jul 22min